These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 34681938)
1. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery. Yeh SJ; Chung MH; Chen BS Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938 [TBL] [Abstract][Full Text] [Related]
2. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer. Yeh SJ; Lin CY; Li CW; Chen BS Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126066 [TBL] [Abstract][Full Text] [Related]
3. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Li CW; Chang PY; Chen BS Oncotarget; 2016 Nov; 7(48):79453-79473. PubMed ID: 27821810 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease. Villa C; Stoccoro A Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893045 [TBL] [Abstract][Full Text] [Related]
5. Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis. Chou SP; Chuang YJ; Chen BS Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409019 [TBL] [Abstract][Full Text] [Related]
7. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease. Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853 [TBL] [Abstract][Full Text] [Related]
8. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease. Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057 [TBL] [Abstract][Full Text] [Related]
9. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584 [TBL] [Abstract][Full Text] [Related]
10. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery. Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136 [TBL] [Abstract][Full Text] [Related]
11. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications. Chang S; Chen JY; Chuang YJ; Chen BS Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269 [TBL] [Abstract][Full Text] [Related]
12. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging. Yeh SJ; Lin JF; Chen BS Molecules; 2021 May; 26(11):. PubMed ID: 34073305 [TBL] [Abstract][Full Text] [Related]
13. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective. Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428 [TBL] [Abstract][Full Text] [Related]
14. Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease. Upadhyaya Y; Xie L; Salama P; Cao S; Nho K; Saykin AJ; Yan J; Alzheimer's Disease Neuroimaging Initiative FT BMC Med Genomics; 2020 Apr; 13(Suppl 5):53. PubMed ID: 32241275 [TBL] [Abstract][Full Text] [Related]
15. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials. Castrillo JI; Lista S; Hampel H; Ritchie CW Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064 [TBL] [Abstract][Full Text] [Related]
16. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease. Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815 [TBL] [Abstract][Full Text] [Related]
17. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
18. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. Yeh SJ; Chang CA; Li CW; Wang LH; Chen BS Oncotarget; 2019 Jun; 10(38):3760-3806. PubMed ID: 31217907 [TBL] [Abstract][Full Text] [Related]
19. Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer's Disease. Singh SK; Kumar A; Singh RB; Ghosh P; Bajad NG Curr Top Med Chem; 2022; 22(26):2153-2175. PubMed ID: 36305125 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease. Ma Y; Wang W; Liu S; Qiao X; Xing Y; Zhou Q; Zhang Z Cells; 2023 Dec; 13(1):. PubMed ID: 38201283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]